GlassScriptPhysician profile
Jimmy Tran
NPI 1306802012
$7,811.64
in general payments reported to CMS, 2019-2025
25 companies · $4,402 in 2025
The $4,402 reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $557 · 2020: $238 · 2021: $251 · 2022: $656 · 2023: $594 · 2024: $1,115 · 2025: $4,402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,335 · Consulting Fee: $1,750 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,335.45 |
| Consulting Fee | $1,750.00 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nordic Pharma, INC. | $1,750.00 | 2025 | Lacrifill |
| Bausch & Lomb Americas INC. | $945.78 | 2023-2025 | Miebo, Xiidra, Envista Envy Iol |
| Glaukos Corporation | $929.54 | 2020-2025 | Idosetr, Istent Inject, Photrexa Viscous and Photrexa |
| Rxsight INC | $638.95 | 2023-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Sun Pharmaceutical Industries INC. | $573.58 | 2019-2025 | Cequa, Ilumya |
| Johnson & Johnson Surgical Vision, INC. | $396.65 | 2021-2025 | Tecnis Iol, Tecnis Simplicity, Veritas Vision System |
| Biotissue Holdings INC. | $393.59 | 2021-2025 | |
| Dompe US, INC. | $317.85 | 2022-2025 | Oxervate |
| Sight Sciences, INC. | $279.24 | 2019-2020 | |
| Allergan, INC. | $239.17 | 2019-2022 | |
| Alcon Vision LLC | $225.88 | 2022-2025 | Tryptyr, Rocklatan, Precision7 |
| Harrow Eye, LLC | $209.59 | 2024-2025 | Vevye |
| Novartis Pharmaceuticals Corporation | $201.01 | 2019-2023 | |
| Abbvie INC. | $189.59 | 2022-2025 | |
| Staar Surgical Company | $119.59 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $79.25 | 2020-2022 | |
| Carl Zeiss Meditec, INC. | $60.36 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $59.05 | 2025 | Xdemvy |
| Oyster Point Pharma, INC. | $53.11 | 2023 | Tyrvaya |
| Abb Con-Cise Optical Group LLC | $39.60 | 2025 | Spectacle Lenses, Contact Lens |
| Rayner Intraocular Lenses Limited | $38.03 | 2022-2025 | Rayone Emv, Rayone Spheric, Rayone Aspheric |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $23.84 | 2021 | |
| Shire North American Group INC | $20.24 | 2019 | |
| Katena Products, INC. (Dba Corza Medical) | $14.64 | 2019 | |
| Coopervision INC. | $13.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jimmy Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.